Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs aimed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where cure alternatives remain limited. Make use of the links below to learn more about our portfolio of cytokine-based immunotherapy